Drug intelligence / Profile preview

bu zhong yi qi tang + zhi xue tang + chuan xin lian kang yan pian mod + tian wang bu xin dan

Development stage: Discontinued
Lead developer: Hebrew University of Jerusalem
Administration: Oral

Overview

Bu Zhong Yi Qi Tang + Zhi Xue Tang + Chuan Xin Lian Kang Yan Pian Mod + Tian Wang Bu Xin Dan is a complex Traditional Chinese Medicine (TCM) therapeutic regimen evaluated for the treatment of chronic childhood immune thrombocytopenia (ITP). The combination consists of four distinct herbal formulations: Bu Zhong Yi Qi Tang (Tonify the Middle and Augment the Qi Decoction), Zhi Xue Tang (Stop Bleeding Decoction), a modified version of Chuan Xin Lian Kang Yan Pian (Andrographis Anti-inflammatory Tablet), and Tian Wang Bu Xin Dan (Emperor of Heaven's Special Pill to Tonify the Heart). This regimen is prescribed based on individual TCM diagnosis to address the underlying autoimmune dysfunction and bleeding symptoms associated with ITP. A Phase 2/3 clinical trial sponsored by Hebrew University investigated this combination's ability to improve platelet counts and quality of life while reducing the need for conventional medications, though the study was ultimately terminated.

Other names: TCM combination for ITP

Beyond the preview

Go deeper on bu zhong yi qi tang + zhi xue tang + chuan xin lian kang yan pian mod + tian wang bu xin dan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on bu zhong yi qi tang + zhi xue tang + chuan xin lian kang yan pian mod + tian wang bu xin dan.

Explore the full profile